Abstract
ABSTRACTCurrent flow cytometric analysis of blood and bone marrow samples for diagnosis of acute myeloid leukemia (AML) relies heavily on manual intervention in both the processing and analysis steps, introducing significant subjectivity into resulting diagnoses and necessitating highly trained personnel. Furthermore, concurrent molecular characterization via cytogenetics and targeted sequencing can take multiple days, delaying patient diagnosis and treatment. Attention-based multi-instance learning models (ABMILMs) are deep learning models which make accurate predictions and generate interpretable insights regarding the classification of a sample from individual events/cells; nonetheless, these models have yet to be applied to flow cytometry data. In this study, we developed a computational pipeline using ABMILMs for the automated diagnosis of AML cases based exclusively on flow cytometric data. Analysis of 1,820 flow cytometry samples shows that this pipeline provides accurate diagnoses of acute leukemia [AUROC 0.961] and accurately differentiates AMLversusB- and T- lymphoblastic leukemia [AUROC 0.965]. Models for prediction of 9 cytogenetic aberrancies and 32 pathogenic variants in AML provide accurate predictions, particularly for t(15;17)(PML::RARA) [AUROC 0.929], t(8;21)(RUNX1::RUNX1T1) [AUROC 0.814], andNPM1variants [AUROC 0.807]. Finally, we demonstrate how these models generate interpretable insights into which individual flow cytometric events and markers deliver optimal diagnostic utility, providing hematopathologists with a data visualization tool for improved data interpretation, as well as novel biological associations between flow cytometric marker expression and cytogenetic/molecular variants in AML. Our study is the first to illustrate the feasibility of using deep learning-based analysis of flow cytometric data for automated AML diagnosis and molecular characterization.
Publisher
Cold Spring Harbor Laboratory
Reference42 articles.
1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood;The Journal of the American Society of Hematology,2022
2. Flow cytometric immunophenotyping for hematologic neoplasms
3. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood;The Journal of the American Society of Hematology,2019
4. Lewis, J. E. & Pozdnyakova, O . Digital assessment of peripheral blood and bone marrow aspirate smears. International Journal of Laboratory Hematology (2023).
5. Dehkharghanian, T. , Mu, Y. , Tizhoosh, H. R. & Campbell, C. J . Applied machine learning in hematopathology. International Journal of Laboratory Hematology (2023).